Robert Rees, PhD

Senior Director, Clinical Programs
Avillion Life Sciences Ltd., London, United Kingdom, United Kingdom

Poster(s):

• (404) Efficacy of as-needed albuterol–budesonide versus albuterol on systemic corticosteroid exposure in participants with mild asthma: BATURA prespecified analysis
  Wednesday, October 29, 2025